Abstract:Background: Cancers, a group of multifactorial complex diseases, are generally caused by mutation of multiple genes or dysregulation of pathways. Identifying biomarkers that can characterize cancers would help to understand and diagnose cancers. Traditional computational methods that detect genes differentially expressed between cancer and normal samples fail to work due to small sample size and independent assumption among genes. On the other hand, genes work in concert to perform their functions. Therefore, it is expected that dysregulated pathways will serve as better biomarkers compared with single genes.Results: In this paper, we propose a novel approach to identify dysregulated pathways in cancer based on a pathway interaction network. Our contribution is three-fold. Firstly, we present a new method to construct pathway interaction network based on gene expression, protein-protein interactions and cellular pathways. Secondly, the identification of dysregulated pathways in cancer is treated as a feature selection problem, which is biologically reasonable and easy to interpret. Thirdly, the dysregulated pathways are identified as subnetworks from the pathway interaction networks, where the subnetworks characterize very well the functional dependency or crosstalk between pathways. The benchmarking results on several distinct cancer datasets demonstrate that our method can obtain more reliable and accurate results compared with existing state of the art methods. Further functional analysis and independent literature evidence also confirm that our identified potential pathogenic pathways are biologically reasonable, indicating the effectiveness of our method.Conclusions: Dysregulated pathways can serve as better biomarkers compared with single genes. In this work, by utilizing pathway interaction networks and gene expression data, we propose a novel approach that effectively identifies dysregulated pathways, which can not only be used as biomarkers to diagnose cancers but also serve as potential drug targets in the future.

Network-based Methods for Identifying Critical Pathways of Complex Diseases: a Survey.

Network-based methods for identifying critical pathways of complex diseases: a survey

Pathway Network Analysis of Complex Diseases Based on Multiple Biological Networks.

Network-based Analysis of Complex Diseases.

A Network-Based Pathway-Expanding Approach for Pathway Analysis

A Network-Based Strategy from the Global Perspective for Identification of Risk Pathways in Complex Diseases

A Review of Pathway Databases and Related Methods Analysis

Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data

Network Methods for Pathway Analysis of Genomic Data

Identifying Network-Based Biomarkers of Complex Diseases from High-Throughput Data

Computational Network Biology: Data, Models, and Applications

A Survey on Computational Approaches to Identifying Disease Biomarkers Based on Molecular Networks.

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

Computational methods for identifying the critical nodes in biological networks.

Identifying Dysregulated Pathways in Cancers from Pathway Interaction Networks

Pathway Mapping And Development Of Disease-Specific Biomarkers: Protein-Based Network Biomarkers

Diversified Control Paths: A Significant Way Disease Genes Perturb the Human Regulatory Network

A Survey on Biomarker Identification Based on Molecular Networks.

Biological Network Approaches and Applications in Rare Disease Studies

Recent Advances in Network-based Methods for Disease Gene Prediction

A network-based pathway-extending approach using DNA methylation and gene expression data to identify altered pathways